TrialJournal for immunotherapy of cancer2026

Morning versus afternoon administration of immune checkpoint inhibitors in metastatic non-small-cell lung cancer.

Rachel T Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.